featured
Effect of Sodium Phenylbutyrate/Taurursodiol on Tracheostomy/Ventilation-Free Survival and Hospitalisation in ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
J. Neurol. Neurosurg. Psychiatr. 2022 May 16;[EPub Ahead of Print], S Paganoni, S Hendrix, SP Dickson, N Knowlton, JD Berry, MA Elliott, S Maiser, C Karam, JB Caress, MA Owegi, A Quick, J Wymer, SA Goutman, D Heitzman, TD Heiman-Patterson, C Jackson, C Quinn, JD Rothstein, EJ Kasarskis, J Katz, L Jenkins, SS Ladha, TM Miller, SN Scelsa, TH Vu, C Fournier, KM Johnson, A Swenson, N Goyal, GL Pattee, S Babu, M Chase, D Dagostino, M Hall, G Kittle, M Eydinov, J Ostrow, L Pothier, R Randall, JM Shefner, AV Sherman, E Tustison, P Vigneswaran, H Yu, J Cohen, J Klee, R Tanzi, W Gilbert, P Yeramian, M CudkowiczFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.